BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD. - Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended September 2021 Under Regulation 33(3)(C ) Of LODR, Related Party Transaction - NIL